
    
      Several treatments have been used in during the Covid-19 pandemic of 2020. Using patients'
      registries from several hospitals in Paris, the investigators retrospectively analyzed
      associations between specific treatments, including but not limited to vaccines targeted
      against SARS-CoV-2, hydroxychloroquine, azithromycin, remdesivir, baricitinib, tocilizumab,
      sarilumab, lopinavir/ritonavir and oseltamivir; and clinical outcomes including, death and
      mechanical ventilation.

      Other outcomes of interest include: acute kidney injury, encephalopathy, need for intensive
      care unit transfers.
    
  